97 results
Page 2 of 5
6-K
EX-99.3
axkvb21q7r5oehkjjsg
8 Mar 21
Filing of the 2020 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
4:20pm
6-K
EX-99.2
bff3rs7
29 Jul 20
2020 Half-year Financial Report
10:13am
6-K
EX-99.2
unx2x7khm153z l3l9
20 Apr 20
Sanofi to present Phase 2 detailed results of its brain-penetrant BTK inhibitor in relapsing multiple sclerosis
9:40am
SC TO-T
EX-99
vxjd3tn1ibz65itqhj
27 Dec 19
Third party tender offer statement
5:27pm
SC TO-C
EX-99.2
sp2yet2vmmz 47
9 Dec 19
Information about tender offer
5:22pm
6-K
EX-99.2
0txe6vquw boeyjmf
29 Jul 19
Half-year Financial Report
10:41am
6-K
EX-99.2
1xkp89wthb9zzlitus8p
18 Dec 18
Current report (foreign)
4:47pm
6-K
EX-99.1
8oa23s9m
18 Nov 14
Current report (foreign)
12:00am
6-K
EX-99.4
uka3qh1z6x8
28 Oct 14
Sanofi delivers Business EPS(1) growth of 10.3% at CER in Q3 2014
12:00am
6-K
EX-99.1
im2jphmcnr bcy3qhkr
2 Jun 14
Sanofi and Lilly announce licensing agreement for Cialis® (tadalafil) OTC
12:00am